carlisle & Associates
generic drug updates News contact carlisle medical
news
generic drug updates
Launch of Generic Aggrenox
Released: 07/01/2015
By: Carl Richie, Pharmacy Director

The generic equivalent of Aggrenox (aspirin/extended release dipyridamole) capsules has just been announced by Teva Pharmaceutical Industries Ltd. in the United States. Aspirin and extended release dipyridamole capsules are used to lower the risk of stroke in people who have had a mini-stroke (transient ischemic attack or TIA) or stroke due to a blood clot.

Generic prescription drugs approved by the FDA are required to have the same active ingredient, strength, dosage form and route of administration as the brand name product. Generic prescription drug manufacturing and packaging sites must pass the same quality standards as those of brand name drugs.

If you have any questions or if we may assist you with your pharmacy needs, please contact us at 800-553-1783 or at pharmacy@carlislemedical.com.

<<Back
 
Company News Releases
Generic Drug Updates
Newsletter Subscription
Newsletter Login
 
 
 
 
 
© Copyright 2018 Carlisle Medical, Inc.
Twitter Twitter Twitter Twitter
disclaimer site map disclaimer